Family Medicine Center for Clinical Research (FMCCR)

The Center for Clinical Research is a University of Miami facility where Family Medicine faculty physicians perform clinical research and provide medical attention to thousands of Miami residents each year. We strive to make a difference in South Florida by making valuable research projects available to a great number of primary care patients. For more information visit the Thomson Centerwatch Profile.

Current Studies

Name of Compound/Drug

IMX-150

Protocol Title

A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet

Sponsor

International Medical Innovations, Inc.

Protocol Number

01-004A

Site Investigator

R. Schwartz, MD
 

Name of Compound/Drug

M10097

Protocol Title

Efficacy and Safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a Sub-Study of the Effect of M10097 on Stable Type II Diabetes Mellitus: A One Year, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study.

Sponsor

Sanofi Aventis

Clinical Research Org

Sanofi Aventis

Protocol Number

LTE6673

Site Investigator

R. Schwartz, MD
 

Name of Compound/Drug

Venlafaxine Extended-Release, Selective Serotonin Reuptake Inhibitors

Protocol Title

An Open-Label, Randomized, Rater-Blinded Study to Compare Rate of Remission in patients with Major Depressive Disorder Treated with Venlafaxine Extended-Release versus Selective Serotonin Reuptake Inhibitors Using Treatment Algorithms

Sponsor

Wyeth-Ayerst Pharmaceuticals

Protocol Number

Site Investigator

R. Schwartz, MD

Name of Compound/Drug

Insulin Dry Powder Pulmonary Inhaler (Exubera®)

Protocol Title

A One-Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera®) on Glycemic Control in Patients with Type 2 Diabetes Mellitus who are Poorly Controlled on a Minimum of Two Oral Anti-Diabetic Agents

Sponsor

Pfizer Pharmaceuticals, Inc.

Clinical Research Org

Kendle

Protocol Number

A2171018

Site Investigator

A. Bryan, MD

Name of Compound/Drug

n/a

Protocol Title

A Multi-Center Prospective Clinical Study to Evaluate the Performance and Clinical Predictive Value of the Invader® HPV HR Molecular Assay and Invader® HPV 16/18 Molecular Assay for the Detection of Human Papillomavirus in Cervical Cytology Studies

Sponsor

Third Wave Technologies, Madison, WI

Clinical Research Org

Health Decisions, Inc., Chapel Hill, NC

Protocol Number

TWT DP0517

Site Investigator

R. Schwartz, MD
 

Name of Compound/Drug

n/a

Protocol Title

 A Multi-National, Multi-Center, Double-Blind, Randomized, Parallel Group Study to Compare the Safety and Efficacy of 200 mg PAR 101 Taken q12h with 125 mg Vancomycin Taken q6g for Ten Days in Subjects with Clostridium difficile-Associated Diarrhea

Sponsor

Optimer Pharmaceuticals

Clinical Research Org

Advanced Biologics, New Hope, PA

Protocol Number

PAR-101.1.C.004

Site Investigator

R. Schwartz, MD

Name of Compound/Drug

Celebrex®

Protocol Title

Study of the Efficacy and Tolerability of Once Daily Celebrex® (celecoxib) and Twice Daily Naproxen vs. Placebo in the Treatment of Hispanic Subjects with Osteoarthritis of the Knee.

Sponsor

Pfizer Pharmaceuticals, Inc.

Clinical Research Org

Omni Care

Protocol Number

Pfizer A3191172

Site Investigator

R. Schwartz, MD